ATE164761T1 - Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung - Google Patents

Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung

Info

Publication number
ATE164761T1
ATE164761T1 AT92915903T AT92915903T ATE164761T1 AT E164761 T1 ATE164761 T1 AT E164761T1 AT 92915903 T AT92915903 T AT 92915903T AT 92915903 T AT92915903 T AT 92915903T AT E164761 T1 ATE164761 T1 AT E164761T1
Authority
AT
Austria
Prior art keywords
collagen
drug release
based compositions
controlled drug
crosslinked
Prior art date
Application number
AT92915903T
Other languages
English (en)
Inventor
Ronald K Yamamoto
Emmett L Bond
Jennifer Devens
Paul Kan-Teh Chang
Original Assignee
Vitaphore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaphore Corp filed Critical Vitaphore Corp
Application granted granted Critical
Publication of ATE164761T1 publication Critical patent/ATE164761T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92915903T 1991-07-09 1992-07-09 Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung ATE164761T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72750891A 1991-07-09 1991-07-09

Publications (1)

Publication Number Publication Date
ATE164761T1 true ATE164761T1 (de) 1998-04-15

Family

ID=24922954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92915903T ATE164761T1 (de) 1991-07-09 1992-07-09 Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung

Country Status (5)

Country Link
EP (1) EP0548344B1 (de)
JP (1) JPH06503840A (de)
AT (1) ATE164761T1 (de)
DE (1) DE69225053T2 (de)
WO (1) WO1993000890A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487895A (en) * 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
CA2140053C (en) * 1994-02-09 2000-04-04 Joel S. Rosenblatt Collagen-based injectable drug delivery system and its use
DE4414755C2 (de) 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6899889B1 (en) * 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US6830756B2 (en) 1998-11-06 2004-12-14 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
JP4340067B2 (ja) 2001-04-23 2009-10-07 ウィスコンシン アルムニ リサーチ ファウンデイション 二機能性改変ハイドロゲル
CN111518288B (zh) * 2020-05-13 2022-06-24 福州大学 一种复合水凝胶伤口敷料及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2824092A (en) * 1955-01-04 1958-02-18 Robert E Thompson Process of preparation of a gelatincarboxymethyl cellulose complex
US4223984A (en) * 1979-04-04 1980-09-23 Opticol Corporation Collagen soft contact lens
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
DE3429038A1 (de) * 1984-08-07 1986-02-20 B. Braun Melsungen Ag, 3508 Melsungen Wirkstoff-depot
SU1321420A1 (ru) * 1985-06-19 1987-07-07 Московский научно-исследовательский институт микрохирургии глаза Способ изготовлени коллагенового покрыти дл использовани в офтальмологии
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system

Also Published As

Publication number Publication date
WO1993000890A1 (en) 1993-01-21
JPH06503840A (ja) 1994-04-28
EP0548344A1 (de) 1993-06-30
DE69225053T2 (de) 1998-10-08
EP0548344A4 (en) 1993-10-27
DE69225053D1 (de) 1998-05-14
EP0548344B1 (de) 1998-04-08

Similar Documents

Publication Publication Date Title
AU3990797A (en) Sustained release formulation
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ES2009346A6 (es) Procedimiento de preparacion de composiciones farmaceuticas que contienen polipeptidos hidroinsolubles.
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
ATE70718T1 (de) Pharmakadepotpraeparat.
ATE306906T1 (de) Verzögerte freisetzung von peptiden aus pharmazeutischen zusammensetzungen
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DK0460020T3 (da) Medikamentleveringssammensætninger
NO934573L (no) Farmasoeytiske formuleringer av oste-orgeniske proteiner
KR920019342A (ko) 골질환 치료제
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
RU94016167A (ru) Фармацевтическая композиция, способы доставки биологически активного вещества, способы лечения, способы стимулирования
DE69225053D1 (de) Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ES2173474T3 (es) Procedimiento para la fabricacion de un implante compuesto de un material portador absorbible que contiene una sustancia activa medica, tal como farmaceutica, antibiotica, citostatica u hormonal.
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
SE8804628D0 (sv) New compounds
ATA80390A (de) Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
DE3883246D1 (de) Auf tocopherol basierte arzneimittelsysteme.
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
ES2090969T3 (es) Composicion inyectable que contiene microcapsulas de colageno.
ES2065696T3 (es) Composicion farmaceutica.
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
CA2036592A1 (en) Therapeutic agent for diabetic gangrene

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties